DrugPatentWatch Database Preview

Details for Patent: 9,289,382

« Back to Dashboard

Which drugs does patent 9,289,382 protect, and when does it expire?

Patent 9,289,382 protects IMVEXXY and is included in one NDA.

This patent has ninety-three patent family members in twelve countries.

Summary for Patent: 9,289,382

Title:	Vaginal inserted estradiol pharmaceutical compositions and methods
Abstract:	According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
Inventor(s):	Bernick; Brian A. (Boca Raton, FL), Amadio; Julia M. (Boca Raton, FL)
Assignee:	TherapeuticsMD, Inc. (Boca Raton, FL)
Application Number:	14/624,051
Patent Claim Types: see list of patent claims	Compound; Delivery;

Drugs Protected by US Patent 9,289,382

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Therapeuticsmd Inc	IMVEXXY	estradiol	INSERT;VAGINAL	208564-001	May 29, 2018		RX	Yes	No			Y
Therapeuticsmd Inc	IMVEXXY	estradiol	INSERT;VAGINAL	208564-002	May 29, 2018		RX	Yes	Yes			Y

International Family Members for US Patent 9,289,382

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	095619
Argentina	098160
Argentina	099872
Argentina	107022
Australia	2012340589
Australia	2013211876